

The world of clinical trials is driven by the generation of data and a wide range of documents which lends themselves to the use of Generative AI for assisting clinical trial processes. The purpose of this White Paper is to take a clear-eyed view of the potential benefits and risks we should anticipate with Generative AI as it applies to medical research—specifically in regard to clinical operations. And in addition, to provide a feasible, focused framework around the areas where GenAI will best serve the interests of healthcare—and improve the lives of clinical trial participants and patients.